SciClone Pharmaceuticals, Inc. (SCLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Size: px
Start display at page:

Download "SciClone Pharmaceuticals, Inc. (SCLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile"

Transcription

1 SciClone Pharmaceuticals, Inc. (SCLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

2 SciClone Pharmaceuticals, Inc. (SCLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or reportstore@bioportfolio.com 2

3 SciClone Pharmaceuticals, Inc. (SCLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary SciClone Pharmaceuticals, Inc. (SciClone) is a US based pharmaceutical company with substantial commercial business in China. SciClone develops and commercializes novel therapies for varied therapeutic areas such as oncology, infectious diseases, cardiovascular, respiratory, urological and central nervous system disorders. The company markets its lead product, Zadaxin in more than 30 countries for the treatment hepatitis B virus and the hepatitis C virus, certain cancers and/or as a vaccine adjuvant. SciClone also markets other pharmaceutical products in China including Depakine, an anti-convulsant; Tritace, an ACE inhibitor; and Stilnox for treatment of insomnia; among others. The company also licenses, promotes, distributes or markets a number of other pharmaceutical products including DC Bead, Abstral, Loramyc, RapidFilm in various countries across the world. SciClone is headquartered in Foster City, California, the US. SciClone Pharmaceuticals, Inc. (SCLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. 3

4 - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH81637D Number of Pages : 29 Report Format : PDF Publisher Information : 4

5 5

6 Table Of Contents for SciClone Pharmaceuticals, Inc. (SCLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 3List of Figures 4SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details 10Partnerships 10Soligenix Enters Into Co-Marketing Agreement With SciClone Pharma For SGX942 10Licensing Agreements 12Theravance Biopharma Enters into Co- Development Agreement with SciClone Pharma 12Medicines Company Enters into Licensing Agreement with SciClone 13SciClone Pharma Enters Into Licensing Agreement With Taiwan Liposome For ProFlow 15SciClone Pharma And Zensun (Shanghai) Science & Technology Enter Into Licensing Agreement For Neucardin 17RESprotect Terminates Licensing Agreement With SciClone Pharma For RP101 18SciClone Pharma Enters Into Licensing Agreement For SCV-07 19SciClone Pharma Plans To Enter Into In-Licensing Agreement 20Equity Offering 21SciClone Pharma Files Registration Statement For Public Offering Of Securities For US$100 Million 21Acquisition 23SciClone Pharma Acquires NovaMed Pharma 23SciClone Pharma Plans To Acquire Pharma Company In China 25SciClone Pharmaceuticals, Inc. - Key Competitors 26Key Employees 27Locations And Subsidiaries 28Head Office 28Other Locations & Subsidiaries 28Appendix 29Methodology 29About GlobalData 29Contact Us 29Disclaimer 29 6

7 List Of Tables in SciClone Pharmaceuticals, Inc. (SCLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Key Facts, SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD SciClone Pharmaceuticals, Inc., Deals By Therapy Area, 2010 to YTD SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD Soligenix Enters Into Co-Marketing Agreement With SciClone Pharma For SGX Theravance Biopharma Enters into Co-Development Agreement with SciClone Pharma 12 Medicines Company Enters into Licensing Agreement with SciClone 13 SciClone Pharma Enters Into Licensing Agreement With Taiwan Liposome For ProFlow 15 SciClone Pharma And Zensun (Shanghai) Science & Technology Enter Into Licensing Agreement For Neucardin 17 RESprotect Terminates Licensing Agreement With SciClone Pharma For RP SciClone Pharma Enters Into Licensing Agreement For SCV SciClone Pharma Plans To Enter Into In-Licensing Agreement 20 SciClone Pharma Files Registration Statement For Public Offering Of Securities For US$100 Million 21 SciClone Pharma Acquires NovaMed Pharma 23 SciClone Pharma Plans To Acquire Pharma Company In China 25 SciClone Pharmaceuticals, Inc., Key Competitors 26 SciClone Pharmaceuticals, Inc., Key Employees 27 SciClone Pharmaceuticals, Inc., Subsidiaries 28 7

8 List Of Figures, Charts and Diagrams in SciClone Pharmaceuticals, Inc. (SCLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD SciClone Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD

9 How to Buy... SciClone Pharmaceuticals, Inc. (SCLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 9